Clinical Trials Directory

Trials / Conditions / Resectable Pancreatic Carcinoma

Resectable Pancreatic Carcinoma

10 registered clinical trials studyying Resectable Pancreatic Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
TerminatedRed Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy fo
NCT05841706
Jonsson Comprehensive Cancer CenterEARLY_Phase 1
RecruitingAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy
NCT04858334
National Cancer Institute (NCI)Phase 2
Active Not RecruitingAcupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoi
NCT04560712
M.D. Anderson Cancer CenterN/A
RecruitingIntravital Microscopy in Human Solid Tumors
NCT03823144
Mayo ClinicN/A
CompletedVX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
NCT03373188
Emory UniversityPhase 1
CompletedPembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Rem
NCT02930902
M.D. Anderson Cancer CenterPhase 1
CompletedNab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients
NCT02427841
OHSU Knight Cancer InstitutePhase 2
CompletedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Fo
NCT02562716
SWOG Cancer Research NetworkPhase 2
CompletedChemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
NCT01959672
University of NebraskaPhase 2
TerminatedPreoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
NCT01333124
National Cancer Center, KoreaPhase 2